Cargando…
Anticancer bioactive peptide combined with docetaxel and its mechanism in the treatment of breast cancer
Breast cancer remains a worldwide public-health issue. Novel drugs that increase the sensitivity and reduce the toxic side effects of chemotherapeutic agents are urgently required. The present study investigated the effect and mechanism of the short-term intermittent administration of an anticancer...
Autores principales: | Li, Xian, Gao, Beibei, Su, Xiulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401194/ https://www.ncbi.nlm.nih.gov/pubmed/32782500 http://dx.doi.org/10.3892/etm.2020.8902 |
Ejemplares similares
-
iTRAQ-based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells
por: Xu, Yanan, et al.
Publicado: (2020) -
Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p
por: Xing, Zhiwei, et al.
Publicado: (2016) -
Bioactive peptides for anticancer therapies
por: Zhang, Yehao, et al.
Publicado: (2023) -
Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022) -
Selecting lncRNAs in gastric cancer cells for directed therapy with bioactive peptides and chemotherapy drugs
por: Han, Wenyan, et al.
Publicado: (2017)